Severe Symptomatic Hyponatremia — Hypertonic Saline

Key Points

• Severe neurologic symptoms drive emergency treatment more than the sodium value alone.
• Confirm hypotonic hyponatremia, but do not delay rescue hypertonic saline in a patient with seizures or coma.
• Use controlled bolus 3% saline with serial reassessment rather than trying to normalize sodium rapidly.
• An early rise of about 4 to 6 mmol/L is usually sufficient to reduce cerebral edema and stop severe symptoms.
• Chronic or duration-unknown hyponatremia carries osmotic demyelination risk if sodium rises too quickly.
• High-risk patients include those with severe hypokalemia, malnutrition, alcohol use disorder, advanced liver disease, or very low starting sodium.
• Urine output can abruptly increase during therapy and cause dangerous spontaneous overcorrection.
• Desmopressin and dextrose 5% can be used to control or reverse excessive correction.
• Potassium repletion contributes to effective sodium correction and must be included in the total plan.

Algorithm

1. Assess airway, breathing, circulation, glucose, seizure activity, and neurologic severity while confirming the sodium result.
2. Obtain serum osmolality, glucose, electrolytes, renal function, urine osmolality, and urine sodium without delaying treatment for severe symptoms.
3. If seizures, coma, or severe neurologic symptoms are attributable to hypotonic hyponatremia, give a protocolized 3% saline bolus.
4. Recheck neurologic status and sodium after the bolus; repeat controlled bolus therapy if severe symptoms persist and the early correction goal has not been reached.
5. Once symptoms improve or sodium has risen about 4 to 6 mmol/L, stop aggressive hypertonic therapy and shift to controlled correction.
6. Monitor serum sodium every 2 to 4 hours during active treatment and track urine output closely.
7. If sodium is rising too quickly or brisk water diuresis develops, use desmopressin and consider dextrose 5% to keep correction within the planned limit.
8. Identify and treat the underlying cause, then establish a longer-term fluid and medication plan.

Clinical Synopsis & Reasoning

Severe symptomatic hyponatremia is defined clinically by the combination of a low serum sodium concentration and neurologic manifestations attributable to acute cerebral swelling. Seizures, marked obtundation, coma, cardiorespiratory distress related to brain edema, and profound confusion are the presentations in which emergency hypertonic saline is most clearly indicated. The absolute sodium concentration matters, but symptom severity, duration of hyponatremia, and the rate at which sodium fell are more important than a single laboratory threshold. A patient with sodium 118 mmol/L after a rapid postoperative fall may be much more symptomatic than a chronically hyponatremic patient with sodium 112 mmol/L whose brain has partially adapted to the low extracellular osmolality.

The first reasoning step is to confirm that the hyponatremia is hypotonic rather than a laboratory artifact or a translocational phenomenon. Measure serum osmolality and review glucose. Hyperglycemia lowers measured sodium through osmotic water movement and should be interpreted with a glucose-corrected sodium estimate. Markedly elevated lipids or proteins can produce pseudohyponatremia when indirect ion-selective electrode methods are used. Once true hypotonic hyponatremia is established, volume status, urine osmolality, urine sodium, medications, adrenal function, thyroid status, renal function, and recent fluid exposure help identify the cause. In severe neurologic presentations, however, etiologic workup must occur in parallel with treatment rather than delaying hypertonic saline.

The central safety problem is balancing two competing brain injuries. Insufficient early correction allows cerebral edema to persist. Excessive correction after chronic adaptation can cause osmotic demyelination syndrome, especially in patients with very low sodium, alcohol use disorder, malnutrition, advanced liver disease, or hypokalemia. The treatment target is therefore not normalization. The immediate goal is a modest increase, commonly about 4 to 6 mmol/L, or enough to clearly improve the severe neurologic manifestation. After that initial rescue phase, correction should slow substantially and serum sodium should be measured frequently because spontaneous water diuresis can cause unexpectedly rapid rises even after hypertonic saline has been stopped.

Treatment Strategy & Disposition

For seizures, coma, or other severe neurologic symptoms attributed to hypotonic hyponatremia, administer 3% sodium chloride as a controlled bolus rather than a slow, open-ended infusion. European guidance commonly uses 150 mL of 3% saline over about 20 minutes, with reassessment and repeat boluses as needed to achieve an early rise of roughly 5 mmol/L. Other established protocols use 100 mL boluses. The exact bolus protocol should follow local policy, but the principle is the same: achieve a small, rapid, measurable correction, reassess symptoms and sodium, and then stop aggressive correction once the immediate neurologic threat has improved.

After initial stabilization, calculate the total sodium change over time, not simply the amount of saline administered. In most chronic or duration-unknown cases, avoid a rise greater than 8 to 10 mmol/L during the first 24 hours and avoid similarly excessive correction on subsequent days. For patients at high risk for osmotic demyelination, a more conservative ceiling of 8 mmol/L in 24 hours is prudent. Potassium replacement itself can raise serum sodium and must be included in the correction plan. Frequent sodium checks, often every 2 to 4 hours during active correction, and close urine-output monitoring are essential. A sudden large dilute urine output is a warning that endogenous vasopressin has fallen and sodium may accelerate upward.

Desmopressin can be used to stop an emerging water diuresis and control the rate of correction. Some centers use a proactive desmopressin strategy in patients at especially high risk for overcorrection, while others give it reactively when urine output increases or sodium begins to rise too quickly. If the safe correction limit has already been exceeded, desmopressin plus electrolyte-free water such as intravenous dextrose 5% can be used to relower sodium toward a safer trajectory. Once the emergency phase is controlled, treatment must address the cause: discontinue offending drugs when possible, replace glucocorticoids for adrenal insufficiency, manage hypovolemia with isotonic fluid, restrict free water in selected SIADH cases, and address heart failure, cirrhosis, kidney disease, nausea, pain, or other triggers of nonosmotic vasopressin release.

Epidemiology / Risk Factors

• Hyponatremia is the most common electrolyte disorder encountered in hospitalized adults.
• SIADH, diuretics, heart failure, cirrhosis, kidney disease, adrenal insufficiency, polydipsia, and postoperative nonosmotic vasopressin release are common causes.
• Thiazide-associated hyponatremia is particularly important in older adults and can recur if the drug is restarted.
• Osmotic demyelination is uncommon but strongly associated with overly rapid correction in high-risk chronic hyponatremia.

Investigations

Hypertonic Saline Quick Guide

Pharmacology

Prognosis / Complications

• Rapid treatment of severe cerebral edema can reverse seizures and encephalopathy without neurologic sequelae.
• Outcome depends heavily on the underlying illness as well as the sodium abnormality itself.
• Overcorrection can produce delayed and potentially permanent neurologic injury from osmotic demyelination.
• Recurrence is common when the underlying driver, medication, fluid intake pattern, or endocrine disorder is not corrected.
• Patients with profound chronic hyponatremia require prolonged monitoring because safe correction often extends beyond the first day.

Patient Education / Counseling

• Explain that treatment aims for controlled improvement rather than immediate normalization of the sodium level.
• Review medications that can contribute, especially thiazides, SSRIs, carbamazepine, oxcarbazepine, and other SIADH-associated agents.
• Give individualized fluid-intake instructions rather than generic advice to drink more water.
• Patients with adrenal insufficiency should understand stress-dose steroid plans and emergency steroid access.
• Advise prompt evaluation for recurrent confusion, seizure, severe headache, vomiting, or marked lethargy.
• After discharge, arrange repeat sodium testing when medication changes or fluid restrictions are part of the plan.

Notes

The emergency treatment of hyponatremia is symptom-directed. A low sodium concentration without severe neurologic manifestations does not automatically justify hypertonic saline, while a patient with seizures or coma from acute hypotonic hyponatremia should not wait for a complete etiologic workup. Controlled bolus therapy is intended to achieve a small early rise that reduces cerebral edema, followed by a deliberately slower phase of correction.

The most preventable serious complication is osmotic demyelination from overcorrection. The sodium trajectory can accelerate suddenly when the cause of vasopressin release resolves, after volume restoration, after glucocorticoid treatment, or when a causative drug is stopped. For that reason, safe management is an active monitoring process rather than a one-time fluid order. Clinicians should document the starting sodium, the planned correction ceiling, cumulative change, urine output, and the threshold for desmopressin or relowering therapy.

References

1. European Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia — Link
2. European Journal of Endocrinology: Severe symptomatic hyponatremia in Europe — Link